Highest-materiality recent filing
UnitedHealth elects all nine director nominees at 2026 annual meeting
All nine director nominees elected with >89% votes cast in favor, broker non-votes excluded.
UnitedHealth to present at BofA Healthcare Conference on May 12, 2026
Senior leaders will discuss strategy, market positions, recent results, and end-market expectations.
UnitedHealth Q1 EPS $6.90; FY guidance raised; Alegeus deal, $2B buyback
Q1 revenues $111.7B (+2% YoY); GAAP EPS $6.90, adjusted $7.23.
UnitedHealth leaders to speak at Barclays Healthcare Conference on Mar 10
Senior leaders will discuss strategy, market positions, recent results, and end-market expectations.
UnitedHealth appoints Dennis Stankiewicz as CAO; Tom Roos moves to Optum Insight CFO
Dennis Stankiewicz appointed Chief Accounting Officer effective March 2, 2026; will continue as Corporate Controller.
UnitedHealth amends Hemsley stock option; adds holding requirement until May 14, 2030
Compensation Committee amended Stephen Hemsley's May 14, 2025 stock option on Feb 23, 2026.
UNH 2025 rev $447.6B (+12%), adj EPS $16.35; 2026 outlook adj EPS >$17.75
Full year 2025 GAAP EPS $13.23, adjusted EPS $16.35 (down from 2024); Q4 adjusted EPS $2.11 vs $0.01 GAAP.
UnitedHealth reaffirms adjusted 2025 EPS guidance from Oct 28, 2025
Management reaffirmed adjusted 2025 EPS expectations during Jan 12, 2026 investor meetings.
UnitedHealth appoints former FDA commissioner Scott Gottlieb as independent director
Scott Gottlieb, former FDA commissioner (2017-2019), appointed effective November 18, 2025.
UnitedHealth amends bylaws to update Delaware registered office and agent
Board approved amendment to Amended and Restated Bylaws effective November 6, 2025.
UnitedHealth to present at UBS Healthcare Conference; no new financial results disclosed
Senior leaders will answer questions at UBS Global Healthcare Conference 2025 on Nov. 10, 2025 at 8:45 a.m. ET.
UnitedHealth Q3 EPS $2.59 ($2.92 adj); rev $113.2B +12%; raises FY25 outlook to ≥$16.25 adj
GAAP EPS $2.59, adjusted EPS $2.92; net margin 2.1% vs 6.0% a year ago.
UnitedHealth reaffirms 2025 adjusted EPS outlook; CMS star ratings in line
Reaffirmed adjusted 2025 EPS expectations per July 29, 2025 guidance; Amedisys acquisition closing in August 2025 expected to be dilutive.
UnitedHealth reaffirms 2025 adjusted EPS outlook; Amedisys deal closed in August, modestly dilutive
Reaffirmed adjusted 2025 EPS guidance previously issued on July 29, 2025.
UnitedHealth Group appoints new lead independent director, creates Public Responsibility Committee
F. William McNabb appointed lead independent director, replacing Michele Hooper; McNabb served as chairman and CEO of Vanguard Group.
UnitedHealth appoints Wayne DeVeydt as CFO effective Sept 2; John Rex becomes strategic advisor
Wayne S. DeVeydt named CFO effective Sept 2, 2025; replaces John F. Rex who becomes strategic advisor.
UnitedHealth Q2 EPS $3.74, cuts FY outlook; cites $1.2B unfavorable items, high medical trend
Q2 revenue $111.6B (+13% YoY); diluted EPS $3.74; adjusted EPS $4.08.
UnitedHealth Group discloses DOJ criminal and civil investigations into Medicare program
Company proactively contacted DOJ after media reports; now complying with formal criminal and civil requests.
UnitedHealth issues $3.0B in notes across four tranches with rates from 4.40% to 5.95%
Issued $3.0B aggregate principal on June 20, 2025, under existing shelf registration (File No. 333-270279).
Compensation Committee cancelled performance RSUs granted to former CEO Andrew Witty on Feb 20, 2025, in connection with his retirement.
UnitedHealth director Andrew Witty resigns from board, won't seek re-election
Board accepted Andrew Witty's resignation as a director, effective May 20, 2025.
CEO Witty steps down; Hemsley returns; 2025 outlook suspended on higher medical costs
Andrew Witty resigns as CEO effective May 12, 2025, for personal reasons; stays as senior advisor.
Heather Cianfrocco appointed EVP Governance, Compliance and Information Security effective May 6, 2025, moving from Optum CEO role.
UnitedHealth Q1 adj EPS $7.20 misses; revises FY2025 guidance down to $26-$26.50 adj EPS
Q1 EPS $6.85 ($7.20 adjusted); revenues $109.6B, up $9.8B YoY.
UnitedHealth Group Reports 2024 Revenues of $400.3 Billion, Up 8%, and Affirms 2025 Outlook
Full year 2024 revenues grew 8% to $400.3 billion, with Q4 revenues of $100.8 billion.
UnitedHealth Group announces death of UnitedHealthcare CEO Brian Thompson
Brian Thompson, CEO of UnitedHealthcare, passed away on December 4, 2024.
UnitedHealth Group issues 2025 guidance: rev $450-455B, adj EPS $29.50-30.00
2025 revenue expected $450B–$455B; 2025 adjusted EPS $29.50–$30.00.
UnitedHealth Group to hold 2024 Investor Conference on Dec 4; will discuss 2025 outlook
Conference for analysts and institutional investors scheduled Dec 4, 2024, at 8:00 a.m. EST in New York City.
UnitedHealth Q3 revenue $100.8B (+9.2% YoY); adj EPS $7.15; MCR 85.2% vs 82.3%
GAAP EPS $6.51 includes $0.28 direct cyberattack response costs; adjusted EPS $7.15 includes $0.12 business disruption.
UnitedHealth Group issues $12B in notes across eight tranches with maturities from 2026 to 2064
Total principal amount $12.0B, including $2.75B of 5.625% notes due 2054 and $1.85B of 5.750% notes due 2064.
UnitedHealth Q2 rev $98.9B, adj. EPS $6.80; cyber costs $0.92; reaffirms FY adj. outlook
Q2 GAAP EPS $4.54 includes $1.28 South America charge and $0.92 cyber impacts; adjusted EPS $6.80.
UnitedHealth Group shareholders reelect all 10 directors at annual meeting
All 10 director nominees elected; Charles Baker received 757M votes for vs 2.2M against.
UnitedHealth Group to present at Bernstein Conference on May 29, 2024
Senior leaders will answer questions at Bernstein's 40th Annual Strategic Decisions Conference on May 29, 2024 at 8:00 a.m. ET.
UNH: Chris Zaetta to succeed Rupert Bondy as Chief Legal Officer effective June 4
Rupert Bondy transitions from EVP, Chief Legal Officer and Corporate Secretary to Senior Counsel and EVP, Governance, Compliance and Security.
UnitedHealth Group to present at BofA Healthcare Conference on May 14, 2024
Senior leaders will participate in a Q&A at the Bank of America Securities 2024 Healthcare Conference on May 14, 2024 at 11:40 a.m. ET.
UnitedHealth Group: Change Healthcare Cyberattack Data Review Ongoing, 80% of Functionality Restored
Data sampling found files containing PHI or PII that could cover a substantial proportion of people in America; no evidence of full medical histories exfiltrated.
UnitedHealth details Mr. Rex's comp: $1.4M salary, 200% cash target, $600K equity
Annual base salary of $1,400,000.
UnitedHealth Q1 net loss $1.53/shr on Brazil sale and cyberattack; adj EPS $6.91, revenue $99.8B
Q1 revenue $99.8B (+$8B YoY); net loss per share $1.53 includes $7B Brazil charge and $0.74 cyberattack impact.
UnitedHealth Group appoints CFO John Rex as President effective April 1, 2024
John Rex, current CFO of UnitedHealth Group, will also serve as President starting April 1, 2024.
UnitedHealth issues $6.0B in notes across six tranches, maturities 2027-2064
Issued $500M 4.600% notes due 2027, $400M 4.700% notes due 2029, $1.0B 4.900% notes due 2031.
UnitedHealth Group provides timeline for restoring Change Healthcare systems after cyberattack
Pharmacy e-prescribing fully functional; claim submission/payment transmission available as of March 7.
UnitedHealth reports cyber breach at Change Healthcare by suspected nation-state actor
Suspected nation-state threat actor gained access to Change Healthcare IT systems on Feb 21, 2024.
UnitedHealth Group completes sale of Brazil operations on Feb 6, 2024
Sale of Brazil operations closed on February 6, 2024, as previously announced.
UnitedHealth Group President and COO Dirk McMahon to retire April 1, 2024
Dirk McMahon (age 64) notified the company on Feb 6, 2024 of his retirement effective April 1, 2024.
UnitedHealth FY2023 rev $371.6B (+15%), adj EPS $25.12; Q4 adj EPS $6.16; affirms 2024 outlook
Full-year revenues $371.6B (+14.6% YoY); earnings from operations $32.4B (+13.8%).
UnitedHealth to sell Brazil operations; expects ~$7B charge, confirms adjusted EPS view
Agreed to sell Brazil operations to a private investor; expected close H1 2024 subject to regulatory conditions.
UnitedHealth Group issues 2024 guidance: revenue $400B-$403B, adjusted EPS $27.50-$28.00
2024 revenue guidance $400B-$403B; adjusted net earnings $27.50-$28.00 per share.
UnitedHealth Group schedules 2023 investor conference for Nov 29, to discuss 2024 outlook
Conference in New York City on Nov 29, 2023 at 8:00 a.m. ET with management presentations.
Charlie Baker appointed to UnitedHealth Group Board of Directors effective Oct 30, 2023
Charles D. Baker (former Massachusetts governor, former CEO of Harvard Pilgrim Health Care) appointed independent director.
UnitedHealth Q3 revenue $92.4B (+14% YoY), EPS $6.24; adj. $6.56; raises FY2023 guidance
Revenue $92.4B (+14% YoY); operating earnings $8.5B (+14% YoY).
the Board of Directors of UnitedHealth Group Incorporated (the “Company”) accepted Andrew Witty’s resignation as a director of the Company, effective immediately.
On May 12, 2025, the Board of Directors of the Company (the “Board”) appointed Steve Hemsley as the Chief Executive Officer of the Company, beginning on the Effective Date.
On May 12, 2025, Andrew Witty, Chief Executive Officer of UnitedHealth Group Incorporated (the “Company”), notified the Company of his decision to step down from his position, effective May 12, 2025
Patrick Conway, M.D., currently Chief Executive Officer of Optum Rx, has been appointed to serve as Chief Executive Officer of Optum on the Effective Date.
Heather Cianfrocco, currently Chief Executive Officer of Optum, has been appointed to serve in the enterprise-wide role of Executive Vice President, Governance, Compliance and Information Security of the Company, effective May 6, 2025
Chris Zaetta, Chief Legal Officer of Optum, will succeed Mr. Bondy to assume the role of the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary on the Effective Date.
Rupert Bondy, the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary, will transition from that role to begin serving as the Company’s Senior Counsel and Executive Vice President, Governance, Compliance and Security, effective June 4, 2024
On March 28, 2024, UnitedHealth Group Incorporated (the “Company”) announced that, effective April 1, 2024, John Rex, the Company’s Chief Financial Officer, has been appointed to serve as the Company’s President in addition to continuing with his existing responsibilities as Chief Financial Officer.
On February 6, 2024, Dirk McMahon (age 64), President and Chief Operating Officer of UnitedHealth Group Incorporated (the “Company”), notified the Company of his decision to retire, effective April 1, 2024.
On November 3, 2023, UnitedHealth Group Incorporated (“the “Company”) issued a press release announcing the appointment of Charles D. Baker to serve as an independent director of the Company, effective October 30, 2023.
On December 12, 2022, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing the appointment of Kristen L. Gil to serve as an independent director of the Company, effective December 9, 2022.
UnitedHealth Group Incorporated (the “Company”) has announced that, effective February 14, 2022, Patricia L. Lewis, the Company’s Executive Vice President and Chief Human Resources Officer, transitioned from that role to begin serving as the Company’s Chief Sustainability Officer.
Max materiality 0.90 · Median 0.50 · Most common event earnings